Patents by Inventor Mitsuyasu Ushijima

Mitsuyasu Ushijima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200147021
    Abstract: Provided is a blood flow improver which is safe and has a mild action. The blood flow improver comprises S-1-propenylcysteine or a salt thereof as an active ingredient.
    Type: Application
    Filed: August 6, 2018
    Publication date: May 14, 2020
    Applicant: WAKUNAGA PHARMACEUTICAL CO., LTD.
    Inventors: Mitsuyasu USHIJIMA, Kayo KUNIMURA, Yukihiro KODERA, Naoaki MORIHARA
  • Patent number: 10363234
    Abstract: Provided is an antihypertensive agent that is safe and has a mild effect. An antihypertensive agent comprising S-1-propenylcysteine or a salt thereof as an active ingredient.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: July 30, 2019
    Assignee: WAKUNAGA PHARMACEUTICAL CO., LTD.
    Inventors: Mitsuyasu Ushijima, Miyuki Takashima, Yukihiro Kodera, Naoaki Morihara
  • Publication number: 20180147170
    Abstract: Provided is an antihypertensive agent that is safe and has a mild effect. An antihypertensive agent comprising S-1-propenylcysteine or a salt thereof as an active ingredient.
    Type: Application
    Filed: June 10, 2016
    Publication date: May 31, 2018
    Applicant: WAKUNAGA PHARMACEUTICAL CO., LTD.
    Inventors: Mitsuyasu USHIJIMA, Miyuki TAKASHIMA, Yukihiro KODERA, Naoaki MORIHARA
  • Publication number: 20080274213
    Abstract: It is intended to provide a highly safe pharmaceutical drug or food that inhibits reduction in blood testosterone level and prevents or ameliorates symptoms and so on associated with male climacteric disorders. The present invention provides a drug for inhibiting reduction in blood testosterone level and a drug for ameliorating male climacteric disorders comprising a plant belonging to the genus Codonopsis or an extract thereof.
    Type: Application
    Filed: May 31, 2005
    Publication date: November 6, 2008
    Applicant: WAKUNAGA PHARMACEUTICAL CO., LTD.
    Inventors: Setsuko Sekita, Masanori Kuroyanagi, Kayo Yasuda, Ikuko Mizuno, Mitsuyasu Ushijima, Minoru Hayama, Makoto Ichikawa, Masanori Sumihiro
  • Patent number: 4816481
    Abstract: Disclosed herein is a cerebral-circulation-metabolism-function-improving agent which contains a 2,6-diphenyl-3,7-dioxabicyclo[3.3.0]octane derivative represented by the following formula as the effective ingredient: ##STR1## wherein, each of R.sub.1, R.sub.3, R.sub.4 and R.sub.6 represents a hydrogen atom or a lower alkoxyl group; each of R.sub.2 and R.sub.5 represents a hydrogen atom, a .beta.-D-glucosyl group or a hydroxyl group; and each of R.sub.7 and R.sub.8 represents an oxygen atom or two hydrogen atoms.
    Type: Grant
    Filed: July 21, 1987
    Date of Patent: March 28, 1989
    Assignee: Wakunaga Seiyaku Kabushiki Kaisha
    Inventors: Naoyuki Takasugi, Mitsuyasu Ushijima, Satoshi Inoue, Terukage Hirata